Worse survival after lung cancer surgery for residents of poor neighborhoods Residents of low-income neighborhoods with few high school graduates may be more likely to die after lung cancer surgery than more affluent patients, a U.S. study finds.
Scientists turn to aspirin to turbo-charge cancer immunotherapy Giving cheap aspirin to cancer patients may turbo-charge the effectiveness of expensive new medicines that help their immune systems fight tumors, experiments on mice suggest.
Chemotherapy for late-stage cancer patients risky, study says Terminally ill cancer patients who received chemotherapy in the last months of life were more likely to die in an intensive care unit than those who did not receive chemo, according to a new study.
Chinese citizens sue government over transparency on Monsanto herbicide Three Chinese citizens are taking China's Ministry of Agriculture to court in a bid to make public a toxicology report supporting the approval of Monsanto's popular weedkiller, Roundup, 27 years ago.
Terminally ill woman choosing to end life checks last item off bucket list A terminally ill woman choosing to end her life in November has crossed off the last item on her bucket list, as she and her family were able to travel to the Grand Canyon last week.
UV exposure may cause drug-like addiction Given the numerous warnings linking sun exposure with skin cancer, why do so many people still worship the sunshine?
The 7 worst things you can say to someone battling breast cancer When you find out someone has breast cancer, it can be hard to know what to say. Even if you have the best of intentions, it's easy to blurt out something that's less-than-helpful.
4 cancer breakthroughs that could save your life Most cancer is still treated with surgery, chemotherapy and radiation. While these often do the job, doctors can’t always predict who will respond.
New 'smart bomb' drug attacks breast cancer, doctors say Doctors successfully drop "smart bomb" on breast cancer in key test.
GSK hopes big clinical trial can breathe new life into lung drug GlaxoSmithKline is banking on a major clinical trial to revive its flagging respiratory medicine business, with billions of dollars of sales riding on a positive result.